Publications

ASAP develops and publishes standards for a variety of pharmacy information needs. You can learn more about these standards and order them online by selecting a category below.

Please Note: If you are not currently an ASAP member, you must become a member when purchasing one of these documents. Therefore you should select the "non-member" rate for the first document you order. ASAP membership is for the individual named on the order and for one year. It does not have to be renewed in order to continue using the document. Please make sure to include your company name and title.

If you have any questions about your ASAP membership status, please call 610-825-7783 or send an email to [email protected]

All documents will be delivered by email as PDFs.
Visa, MasterCard, and American Express accepted online via PayPal.

To request an invoice, pay by check, or pay with a credit card outside of PayPal, please call (610)825-7783

Prescription Monitoring Programs

2020 ASAP Version 4.2B Standard for Prescription Drug Monitoring Programs

Version 4.2B is now the latest version of the American Society for Automation in Pharmacy’s (ASAP) standard used to report drugs dispensed to prescription drug monitoring programs. Version 4.2B addresses changes needed by PDMPs to improve the quality and scope of the data reported.

Non-Member Rate - $995

(Includes one-year individual membership)

Name/Company for Member Roster

Member Rate - $245

(Specify member company/name in "Note to Seller" field during payment)

Member Name/Company

2016 ASAP Version 4.2A Standard for Prescription Drug Monitoring Programs

This version of the ASAP PDMP IG includes several refinements to 4.2 to improve the data collected by prescription-monitoring programs, including changes to the PHA, DSP, and PRE segments. Stakeholders taking part in the updating process included a number of states with operational prescription-monitoring programs, national drug chains and independents, and pharmacy system vendors. ASAP standards are used by every state with a prescription-monitoring program, and states ready to implement a PDMP will be using the ASAP standard. Also included is the versions of both the ASAP Error Reports and Zero Reports standards updated to reflect this latest PDMP IG. Both of which are also available for purchase separately. The combined 65-page PDF includes sample transactions to aid software developers.

Non-Member Rate - $975

(Includes one-year individual membership)

Name/Company for Member Roster

Member Rate - $225

(Specify member company/name in "Note to Seller" field during payment)

Member Name/Company

2011 ASAP Version 4.2 Standard for Prescription Monitoring Programs

This version of the ASAP PMP IG includes several refinements to 4.1 to improve the data collected by prescription-monitoring programs. Stakeholders taking part in the updating process included a number of states with operational prescription-monitoring programs, national drug chains and independents, and pharmacy system vendors. ASAP standards are used by every state with a prescription-monitoring program, and states ready to implement a PMP will be using the ASAP standard. Also included is the Version 1.0 of both the ASAP Error Reports and Zero Reports standards, both of which are also available for purchase separately. The combined 64-page PDF includes sample transactions to aid software developers.

Non-Member Rate - $975

(Includes one-year individual membership)

Name/Company for Member Roster

Member Rate - $225

(Specify member company/name in "Note to Seller" field during payment)

Member Name/Company

Implementation Guide ASAP 4.2 Reporting Standard for Prescription Monitoring Programs NIEM XML Version

The ASAP NIEM XML standard represents the same data elements and high-level transmission report structure as defined by the segments outlined in the core text-based EDI 4.2 implementation guide. The ASAP NIEM XML implementation guide defines a transmission report of controlled substances dispensed and a transmission acknowledgement.

Non-Member Rate - $925 (Includes one-year individual membership)

Member Rate - $175 (Specify member company/name in "Note to Seller" field during payment)

Non-Member Rate - $975

(Includes one-year individual membership)

Name/Company for Member Roster

Member Rate - $225

(Specify member company/name in "Note to Seller" field during payment)

Member Name/Company

2009 ASAP Version 4.1 Standard for Prescription Monitoring Programs

This release of the ASAP standard for prescription monitoring programs is backward compatible with Version 4.0 that was released in 2007. Version 4.1, as with 4.0 can be used for real-time reporting as well as batch reporting. A number of refinements were made to improve the quality of the data reported to prescription monitoring programs. It also includes data elements that address electronic prescriptions transmitted to the pharmacy, once controlled substances can be electronically transmitted. Also included is the Version 1.0 of both the ASAP Error Reports and Zero Reports standards, both of which are also available for purchase separately. The combined 64-page PDF includes sample transactions to aid software developers.

Non-Member Rate - $975

(Includes one-year individual membership)

Name/Company for Member Roster

Member Rate - $225

(Specify member company/name in "Note to Seller" field during payment)

Member Name/Company

2010 ASAP Prescription Monitoring Program Standards Versions 1.0 for PMP Zero Reports and Error Reports

The ASAP Error Reports standard is designed to eliminate the need for retail chains and pharmacy system vendors to support different formats and content of error reports received from prescription monitoring programs. The standard includes a minimum data set to identify the records that have errors or missing information in the batch files submitted. The standard should improve compliance in correcting and resending the records in question. Also included is a standard format for the summary reports pharmacies receive.

Non-Member Rate - $975

(Includes one-year individual membership)

Name/Company for Member Roster

Member Rate - $100

(Specify member company/name in "Note to Seller" field during payment)

Member Name/Company

2015 ASAP Prescription Monitoring Program Web Service Standard 2.1A Implementation Guide

For bidirectional electronic connections between pharmacies, prescribers, and prescription monitoring programs. The PDF includes a Web service example program to implement the standard.

Non-Member Rate - $925

(Includes one-year individual membership)

Name/Company for Member Roster

Member Rate - $175

(Specify member company/name in "Note to Seller" field during payment)

Member Name/Company

REMS Program

2012 Implementation Guide ASAP Standard for Real-Time Safety Adjudication for REMS ETASU Programs 1.2

The purpose of the Real-Time Safety Adjudication Standard is to provide retail pharmacies, switches, intermediaries, RiskEvaluation and Mitigation Strategy (REMS) administrators, and Elements to Assure Safe Use (ETASU) databases with a real-time electronic transaction set. This transaction set will provide for the safety adjudication of real-time pharmacy transactions.

The 105-page PDF includes sample transactions to aid software developers and a W3C XSD Real-Time Safety Adjudication Schema.

Non-Member Rate - $925

(Includes one-year individual membership)

Name/Company for Member Roster

Member Rate - $175

(Specify member company/name in "Note to Seller" field during payment)

Member Name/Company

Medication Therapy Management

2009 Implementation Guide ASAP Standard for Medication Therapy Management Information Exchange 1.0

This is a standard to facilitate information exchange between MTM companies such as Mirixa and Outcomes and the pharmacies in their networks via computer-to-computer notification of MTM opportunities. This can also support a bidirectional information exchange to allow pharmacies to populate the MTM's patient files with medications that were not submitted to the patient's insurance plan as well as OTCs that may be on file in the pharmacy (with the patient’s consent).

This 21-page document includes sample transmissions for software developers.

Non-Member Rate - $875

(Includes one-year individual membership)

Name/Company for Member Roster

Member Rate - $125

(Specify member company/name in "Note to Seller" field during payment)

Member Name/Company

Pseudoephedrine Tracking

2012 Implementation Guide, ASAP Standard for Pseudoephedrine (PSE)-Tracking Programs 1.2

This implementation guide is designed for reporting PSE product sales by pharmacies and general retail outlets. The standard can be used to report product sales in real time or as a batch file. In addition to reporting PSE product sales, it can be used to query a database prior to a sale. It can also handle hard-stop sales and hard-stop overrides.

Non-Member Rate - $925

(Includes one-year individual membership)

Name/Company for Member Roster

Member Rate - $175

(Specify member company/name in "Note to Seller" field during payment)

Member Name/Company

X12 EDI

X12 EDI Guidelines

These are Implementation Guidelines for ASC X12 004010 transactions to support pharmacy/wholesaler electronic data interchange. The following transactions are included:

850 Purchase Order
855 Purchase Order Acknowledgement
997 Functional Acknowledgement
832 Sales/Price Catalog
810 Electronic Invoice
180 Return Notification and Authorization
820 Payment Order and Remittance Advice
846 Inventory Inquiry and Advice
864 Text Message


This document contains complete examples for each of the transaction sets.

Non-Member Rate - $1,085

(Includes one-year individual membership)

Name/Company for Member Roster

Member Rate - $335

(Specify member company/name in "Note to Seller" field during payment)

Member Name/Company

ASAP Cost-Benefit Analysis on the Value of Technology (Feb. 2014)

Introduction

The American Society for Automation in Pharmacy (ASAP) undertook a cost-benefit analysis in 2009 to show the cost that pharmacies incur in the use of technology and how it serves to improve patient safety, patient adherence, and serves to reduce fraud and abuse. We believe that the investment in technology used to deliver needed medications to millions of Americans each and every day is simply overlooked or taken for granted by state and federal governments, third-party payers, and others. This document is an update of the analysis published in 2009. As part of the update we decided to also include an analysis of the technology used in closed-door pharmacies servicing long-term care facilities.

Methodology

In order to develop the cost factors as fully as possible, we solicited input from technology vendors and the users of the technology. Breakpoints were selected based upon the levels at which additional technology components are typically purchased. While purchase decisions are generally individualized to address the specific needs of each pharmacy, we found considerable agreement regarding the breakpoints at which technology is added and the components that are most often added. Depreciation was calculated on a four-year, straight-line basis. While some variability exists in the way that vendor service agreements are handled, we found that certain services and third-party database components are bundled into regular maintenance fees by most vendors. Consequently, we did not attempt to break out the cost of each component. Finally, total costs are presented as an average of the per prescription cost to dispense.

Pharmacy technology clearly requires a significant capital outlay, plus ongoing support and upgrade costs. However, specific benefits are difficult to connect with specific cost factors. We decided to categorize the benefits of key technology components into three areas: patient safety, adherence, and fraud and abuse prevention. Included in this report is a table showing a breakdown of the various technologies and how they apply to each category.

We did not attempt to allocate the percentage of the cost per prescription that would benefit safety and adherence or reduce fraud and abuse. We are leaving it up to the user of the data to make this determination. It should also be noted that we did not attempt to determine the return on investment. This was not the purpose. Once again, the focus of this study was to determine the cost that is added to a prescription based on the technology used in the pharmacy and the benefits derived by the consumer. The costs do not represent the total cost to fill a prescription, only the technology costs associated with the prescription.

The ASAP membership was invited to offer comments to our findings in 2009. We had broad participation and the suggestions offered were incorporated into that final document.

There were no comments challenging the breakpoints or the costs used for the various technologies included. Because of this we feel confident that our updated costs are valid representations. As for the costs and benefits associated with closed-door pharmacies servicing nursing homes, the input we received from pharmacists with experience in this area made us feel comfortable with the cost shown.
We did not attempt to separate hardware and software costs, since it is common industry practice to bundle hardware and software, making it difficult to segregate the two. Likewise we did not attempt to identify the specific costs associated with hardware maintenance. Rather, we decided to apply a percentage of the total investment cost to cover support costs in general.

Intended Use

We encourage the use of these findings, if it is felt the data will serve to improve reimbursement and open up new opportunities for pharmacy in providing technology-based services. We ask that reference be given to ASAP as the source.